Mükerrem Betül Yerer

19PUBLICATIONS
37CO-AUTHORS
Food technologyMolecular targetsFood properties (incl. characteristics and health benefits)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 28, 2026
Technological Innovation and Consumer Trust: Understanding Safety Perceptions in Next Generation Probiotic Development.

|Apr 14, 2025
Effects of empagliflozin and its combination with docetaxel on LNCaP and DU- 145 prostate cancer cell lines: cytotoxicity and molecular pathway analysis.

Ahmet Cumaoğlu, Selda Nur Akdeniz, Ahmad Karzoon

|Jul 27, 2024
Empagliflozin demonstrates cytotoxicity and synergy with tamoxifen in ER-positive breast cancer cells: anti-proliferative and anti-survival effects.

Ahmad Karzoon, Mükerrem Betül Yerer, Ahmet Cumaoğlu

|Aug 26, 2023
Cancer and Nutrients.

Hardeep Singh Tuli, Mukerrem Betul Yerer, Vikas Yadav

|Apr 06, 2023
Risk factors for early onset acute kidney injury after allogeneic haematopoietic stem cell transplantation and the role of drug-drug interactions.

Ayşe Günay, Ali Ünal, Eren Demirpolat

|Jan 08, 2023
Novel Strategies for the Bioavailability Augmentation and Efficacy Improvement of Natural Products in Oral Cancer.

Alisha Sachdeva, Dimple Dhawan, Gaurav K Jain

Pageof 4

Frequent Collaborators

4 joint publications

Katrin Sak

4 joint publications

Ahmet Cumaoğlu

2 joint publications

Ayşe Günay

2 joint publications

Eren Demirpolat